We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 29, 2021

Insulin Degludec U100 vs Glargine U100 for Inpatient Type 2 Diabetes Management

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
A Randomised Controlled Trial Comparing Insulin Degludec U100 and Glargine U100 for the Inpatient Management of Patients with Type 2 Diabetes
Diabetes Obes Metab 2021 Sep 06;[EPub Ahead of Print], RJ Galindo, FJ Pasquel, P Vellanki, R Alicic, DW Lam, M Fayfman, AL Migdal, GM Davis, S Cardona, MA Urrutia, C Perez-Guzman, KW Zamudio-Coronado, L Peng, KR Tuttle, GE Umpierrez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading